170479 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants; Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3 T-cell receptor (TcR)-CD3 complex
Methods for diagnosis, prognosis and methods of treatment
#302TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIGENS AND METHODS OF USE
#303CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS
#304Tolerogenic synthetic nanocarriers for allergy therapy
#305TOLEROGENIC SYNTHETIC NANOCARRIERS FOR REGULATING INNATE IMMUNE RESPONSES
#306Tolerogenic synthetic nanocarriers
#307Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses
#308TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#309TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE GRAFT ANTIGENS AND METHODS OF USE
#310Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#311Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#312Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#313Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
#314Ki-67 ASSAY FOR PATIENT IMMUNE SYSTEM STATUS
#315LAT adapter molecule for enhanced T-cell signaling and method of use
#316BIOMARKER FOR MONITORING PATIENTS
#317BIOMARKERS FOR THE TREATMENT OF PSORIASIS
#318MAGNETIC NANOPARTICLE AND METHOD FOR IMAGING T CELLS
#319Kit for diagnosis, prognosis, and monitoring the immune status, of patients with chronic inflammatory diseases
#320Compositions and methods of detecting TIABs
#321Methods, devices, and systems for chemiluminescence-based microfluidic cell counting
#322Method for identifying a T-cell receptor protective against a disease
#323Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4
#324Hematopoietic cell phenotyping using circulating cell-free markers
#325HIGH AFFINITY TCR PROTEINS AND METHODS
#326Device and methods for detecting a target cell
#327T Cell Adhesion Molecule and Antibody Thereto
#328Model System for TCR (ZETA) Chain Downregulation
#329Isolating Cells Expressing Secreted Proteins
#330Methods for diagnosis prognosis and methods of treatment
#331Method of analyzing lymphocytes
#332Immunogenic fragments of T-cell receptor constant domains and peptides derived therefrom
#333Methods for the Diagnosis and Prognosis of Graft Versus Host Disease By Measurement of Peripheral Cd3+Cd4+Cd8Beta+ Cells
#334Methods To Identify, Prepare, And Use Naive T Cell Recent Thymic Emigrants
#335Method for determining the immune status of a subject
#336Hematopoietic cell phenotyping using free circulating cellular markers
#337Isolated T lymphocyte receptors specific for human autoantigens complexed with human MHC molecules and methods of making and using same
#338Soluble TCR molecules and methods of use
#339Method for identifying a shared neoantigen-reactive T cell receptor
#340Lyme disease-associated T cell receptor-related methods